1,4-disubstituted piperazine ligands for neurotransmitter receptors
AssigneeSepracor Inc.
InventorsJames R. Hauske, Joanne M. Holland, Heike S. Radeke
Life of this patent
Estimating the term…
Loading patent…
AssigneeSepracor Inc.
InventorsJames R. Hauske, Joanne M. Holland, Heike S. Radeke
Estimating the term…
One aspect of the present invention relates to novel heterocyclic compounds. A second aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for various cellular receptors, including serotonin receptors and dopamine receptors. The compounds of the present invention will find use in the treatment of numerous ailments, conditions and diseases which afflict mammals, including but not limited to addiction, anxiety, depression, sexual dysfunction, hypertension, migraine, Alzheimer's disease, obesity, emesis, psychosis, analgesia, schizophrenia, Parkinson's disease, restless leg syndrome, sleeping disorders, attention deficit hyperactivity disorder, irritable bowel syndrome, premature ejaculation, menstrual dysphoria syndrome, urinary incontinence, inflammatory pain, neuropathic pain, Lesche-Nyhane disease, Wilson's disease, Tourette's syndrome, psychiatric disorders, stroke, and senile dementia.
A compound represented by A:
Dependencies are inferred from the claim text.